SEC 13F Intelligence

Hanseatic Management Services Inc / ITCIEUR

Hanseatic Management Services Inc’s Intra-Cellular Therapies Inc Position

Does Hanseatic Management Services Inc own Intra-Cellular Therapies Inc (ITCIEUR)? Not currently — the last reported position was 10.2K shares worth $583,000 in Q2 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$583,000
Q2 2022
Shares
10.2K
% of Portfolio
+1.33%
Quarters Held
2
position exited

Position History ITCIEUR

Reported value by quarter
Q1 ’22: $610,000Q1 ’22Q2 ’22: $583,000Q2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202210.2K$583,000+1.33%
Q1 202210.0K$610,000+1.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hanseatic Management Services Inc’s full portfolio or all institutional holders of ITCIEUR.